Liver metastasis is the only independent prognostic factor in AFP-producing gastric cancer

World Journal of Gastroenterology

Volumn 19, Issue 36, 2013, Pages 6055-6061

  Hirajima, Shoji ^a   Komatsu, Shuhei ^a   Ichikawa, Daisuke ^a   Kubota, Takeshi ^a   Okamoto, Kazuma ^a   Shiozaki, Atsushi ^a   Fujiwara, Hitoshi ^a   Konishi, Hirotaka ^a   Ikoma, Hisashi ^a   Otsuji, Eigo ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Gastric cancer; Immunostaining; Liver metastasis; Poor prognosis; fetoprotein

Indexed keywords

ALPHA FETOPROTEIN; CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER RECURRENCE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISTANT METASTASIS; ENDOSCOPY; FEMALE; FOLLOW UP; GASTRECTOMY; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; STOMACH CANCER; SURVIVAL RATE; THORAX RADIOGRAPHY;

GASTRIC CANCER; IMMUNOSTAINING; LIVER METASTASIS; POOR PROGNOSIS; Α-FETOPROTEIN;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ALPHA-FETOPROTEINS; BIOPSY; CHI-SQUARE DISTRIBUTION; FEMALE; GASTRECTOMY; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; STOMACH NEOPLASMS; TIME FACTORS;

EID: 84885616948     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i36.6055     Document Type: Article

References (25)

1. Bergstrand CG, Czar B. Demonstration of a new protein fraction in serum from the human fetus. Scand J Clin Lab Invest 1956; 8: 174 [PMID: 13351554]
2. Nishimura H, Okamoto Y, Takahashi M, Fujita T. Occurrence of alpha-fetoprotein, Regan isoenzyme, and variant alkaline phosphatase in the serum of a patient with gastric cancer. Gastroenterology 1976; 71: 497-499 [PMID: 59676]
3. Masuzawa M, Lee PK, Kamada T, Akeyama T, Abe H, Shimano T, Mori T, Morino H, Ishiguro S. Carcinoembryonic antigen, alpha-fetoprotein and carcinoplacental alkaline phosphatase in gastric carcinoma metastatic to the liver. Cancer 1977; 39: 1175-1180 [PMID: 71944]
4. Kodama T, Kameya T, Hirota T, Shimosato Y, Ohkura H, Mukojima T, Kitaoka H. Production of alpha-fetoprotein, normal serum proteins, and human chorionic gonadotropin in stomach cancer: histologic and immunohistochemical analyses of 35 cases. Cancer 1981; 48: 1647-1655 [PMID: 6169423]
5. Ooi A, Okada Y, Minamoto T, Imabori T, Shima K. [A case of alpha-fetoprotein-producing gastric carcinoma with histologic features of embryonal carcinoma]. Gan No Rinsho 1985; 31: 334-340 [PMID: 2582159]
6. Koyama S, Ebihara T, Osuga T. Histologic and immunohistochemical studies of alpha-fetoprotein (AFP)-producing gastric carcinoma. Gastroenterol Jpn 1987; 22: 419-427 [PMID: 2444485]
7. Kono K, Amemiya H, Sekikawa T, Iizuka H, Takahashi A, Fujii H, Matsumoto Y. Clinicopathologic features of gastric cancers producing alpha-fetoprotein. Dig Surg 2002; 19: 359-365; discussion 365 [PMID: 12435906]
8. Chang YC, Nagasue N, Kohno H, Taniura H, Uchida M, Yamanoi A, Kimoto T, Nakamura T. Clinicopathologic features and long-term results of alpha-fetoprotein-producing gastric cancer. Am J Gastroenterol 1990; 85: 1480-1485 [PMID: 1700600]
9. Chun H, Kwon SJ. Clinicopathological characteristics of alpha-fetoprotein-producing gastric cancer. J Gastric Cancer 2011; 11: 23-30 [PMID: 22076198 DOI: 10.5230/ jgc.2011.11.1.23]
10. Liu X, Cheng Y, Sheng W, Lu H, Xu Y, Long Z, Zhu H, Wang Y. Clinicopathologic features and prognostic factors in alphafetoprotein-producing gastric cancers: analysis of 104 cases. J Surg Oncol 2010; 102: 249-255 [PMID: 20740583 DOI: 10.1002/ jso.21624]
11. McIntire KR, Waldmann TA, Moertel CG, Go VL. Serum alpha-fetoprotein in patients with neoplasms of the gastrointestinal tract. Cancer Res 1975; 35: 991-996 [PMID: 46783]
12. Bourreille J, Metayer P, Sauger F, Matray F, Fondimare A. [Existence of alpha feto protein during gastric-origin secondary cancer of the liver]. Presse Med 1970; 78: 1277-1278 [PMID: 5426134]
13. Chang YC, Nagasue N, Abe S, Kohno H, Yamanoi A, Uchida M, Nakamura T. [The characters of AFP-producing early gastric cancer]. Nihon Geka Gakkai Zasshi 1990; 91: 1574-1580 [PMID: 1702182]
14. Motoyama T, Aizawa K, Watanabe H, Fukase M, Saito K. alpha-Fetoprotein producing gastric carcinomas: a comparative study of three different subtypes. Acta Pathol Jpn 1993; 43: 654-661 [PMID: 7508672]
15. Chang YC, Nagasue N, Abe S, Taniura H, Kumar DD, Nakamura T. Comparison between the clinicopathologic features of AFP-positive and AFP-negative gastric cancers. Am J Gastroenterol 1992; 87: 321-325 [PMID: 1371637]
16. Koide N, Nishio A, Igarashi J, Kajikawa S, Adachi W, Amano J. Alpha-fetoprotein-producing gastric cancer: histochemical analysis of cell proliferation, apoptosis, and angiogenesis. Am J Gastroenterol 1999; 94: 1658-1663 [PMID: 10364040]
17. Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma-2nd English Edition-Gastric Cancer 1998; 1: 10-24 [PMID: 11957040]
18. Sobin LH, Gospodarowicz MK, Wittekind C. TNM classification of Malignant Tumors. 7th ed. New York: Wiley-Liss, 2009
19. Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, Shen L, Sawaki A, Lordick F, Ohtsu A, Omuro Y, Satoh T, Aprile G, Kulikov E, Hill J, Lehle M, Rüschoff J, Kang YK. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, openlabel, randomised controlled trial. Lancet 2010; 376: 687-697 [PMID: 20728210 DOI: 10.1016/S0140-6736(10)61121-X]
20. Boku N, Yamamoto S, Fukuda H, Shirao K, Doi T, Sawaki A, Koizumi W, Saito H, Yamaguchi K, Takiuchi H, Nasu J, Ohtsu A. Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study. Lancet Oncol 2009; 10: 1063-1069 [PMID: 19818685 DOI: 10.1016/S1470-2045(09)70259-1]
21. Kim JH, Jang YJ, Park SS, Park SH, Mok YJ. Benefit of postoperative surveillance for recurrence after curative resection for gastric cancer. J Gastrointest Surg 2010; 14: 969-976 [PMID: 20411347 DOI: 10.1007/s11605-010-1200-4]
22. Koizumi W, Narahara H, Hara T, Takagane A, Akiya T, Takagi M, Miyashita K, Nishizaki T, Kobayashi O, Takiyama W, Toh Y, Nagaie T, Takagi S, Yamamura Y, Yanaoka K, Orita H, Takeuchi M. S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol 2008; 9: 215-221 [PMID: 18282805 DOI: 10.1016/S1470-2045(08)70035-4]
23. Yabusaki H, Nashimoto A, Tanaka O. [A case of AFPproducing gastric cancer after curative operation effectively treated with chemotherapies including hepatic arterial infusion therapy]. Gan To Kagaku Ryoho 2000; 27: 735-738 [PMID: 10832443]
24. Sobajima J, Murata N, Ishida H, Hashimoto D, Adachi A, Itoyama S. [A case of postoperative liver metastasis of alphafetoprotein producing gastric cancer successfully treated with intrahepatic chemotherapy (adriamycin, cisplatin, irinotecan hydrochloride)]. Gan To Kagaku Ryoho 2002; 29: 2132-2134 [PMID: 12484020]
25. Takada J, Kenno S, Aoki T, Hamada H, Katsuki Y. [A case in which intra-arterial chemotherapy for simultaneous hepatic metastases markedly improved AFP-producing gastric cancer]. Gan To Kagaku Ryoho 2009; 36: 2326-2329 [PMID: 20037411]